Skip to main content

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in FDMT — 4D Molecular Therapeutics, Inc.

CIK 861177 NEW YORK, NY

Position in FDMT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$9,190
+$2,757 QoQ
Shares Held
691
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#132
of 158 holders
Holding Since
Dec 2021
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in FDMT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,243 across 206 Biotechnology names. FDMT ranks #171 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in FDMT

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,190 691
2026-03-31 $6,433 691
2024-12-31 $246,884 44,324
2024-09-30 $447,522 41,399
2024-06-30 $1,000,214 47,652
2024-03-31 $1,022,004 32,078
2023-12-31 $477,892 23,588
2023-09-30 $300,275 23,588
2023-06-30 $183,392 10,149
2023-03-31 $174,461 10,149
2022-09-30 $216,227 26,894
2022-06-30 $92,010 13,182
2022-03-31 $199,311 13,182
2021-12-31 $289,213 13,182